1Selcuk Adabag,Henri Roukoz,Inder S. Anand,Arthur J. Moss.??Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure(J)Journal of the American College of Cardiology . 2011 (9)
1Sonna M. Patel-Raman,Eric A. Chen.Past, Present, and Future Regulatory Aspects of Ventricular Assist Devices[J]. Journal of Cardiovascular Translational Research . 2010 (6)
2Jacobs B.Reducing heart failure hospital readmissions from skilled nursing facilities. Prof Case Manag . 2011
3Moss AJ.Preventing heart failure and improving survival. The New England Journal of Medicine . 2010
4Ensor CR,Paciullo CA,Cahoon Jr WDet al.Pharmacotherapy for Mechanical Circulatory Support:A Comprehensive Review(January). Annals of Pharmacotherapy . 2011
5Cowie MR.Improving the management of chronic heart failure. Practitioner . 2010
6Taylor J.Focused update of the ESC Guidelines on device therapy in heart failure. European Heart Journal . 2010
7Focused Update of ESC Guidelines on Device Therapy in Heart Failure. Revista Espanola de Cardiologia . 2010
8Dickstein K,Vardas PE,Auricchio Aet al.2010 focused update of ESC Guidelines on device therapy in heart failure:an update of the2008ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the2007ESC Guidelines for cardiac and resynchronization therapy.Developed wi. European Journal of Heart Failure . 2010
9Ghio S,Freemantle N,Scelsi Let al.Long-term left ventricular reverse remodelling with cardiac resynchronization therapy:results from the CARE-HF trial. European Journal of Heart Failure . 2009
10Addison D,Aguilar D.Diabetes and Cardiovascular Disease:The Potential Benefit of Incretin-Based Therapies. Current Atherosclerosis Reports . 2010
